H-VSDK-OH

Rif. 3D-PP47971

Informazioni sul prodotto

• Nome: H-VSDK-OH

Descrizione

Peptide H-VSDK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VSDK-OH include the following: Characterization of asparagine 330 deamidation in an Fc-fragment of IgG1 using cation exchange chromatography and peptide mapping YT Zhang, J Hu, AL Pace, R Wong, YJ Wang - of Chromatography B, 2014 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1570023214004127 DockCoV2: a drug database against SARS-CoV-2 TF Chen , YC Chang , Y Hsiao , KH Lee - Nucleic Acids , 2021 - academic.oup.comhttps://academic.oup.com/nar/article-abstract/49/D1/D1152/5920447 Computer based screening for novel inhibitors against Vibrio cholerae using NCI diversity set-II: An alternative approach by targeting transcriptional activator ToxT SI Mondal , B Khadka , A Akter , PK Roy - Interdisciplinary Sciences , 2014 - Springerhttps://link.springer.com/article/10.1007/s12539-012-0046-8 Function-structure approach reveals novel insights on the interplay of Immunoglobulin G 1 proteoforms and Fc gamma receptor IIa allotypes S Lippold , K Mistry, S Lenka , K Whang, P Liu - Frontiers in , 2023 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1260446/full Coupling anion exchange chromatography with native mass spectrometry for charge heterogeneity characterization of monoclonal antibodies AP Liu , Y Yan , S Wang , N Li - Analytical chemistry, 2022 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.2c00707 In silico studies on novel inhibitors of MERS-CoV: Structure-based pharmacophore modeling, database screening and molecular docking AA Radwan , FK Alanazi - Tropical Journal of Pharmaceutical Research, 2018 - ajol.infohttps://www.ajol.info/index.php/tjpr/article/view/170833 High throughput screening, docking, and molecular dynamics studies to identify potential inhibitors of human calcium/calmodulin-dependent protein kinase IV A Beg , FI Khan , KA Lobb , A Islam - Journal of , 2019 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/07391102.2018.1479310

• Marchio: Biosynth